Life Science Investing Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates 07 August
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference 05 August
Life Science Investing Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases 24 July
